BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10811010)

  • 1. Shared features of transcription: mutational analysis of the eosinophil/basophil Charcot-Leyden crystal protein gene promoter.
    Dyer KD; Rosenberg HF
    J Leukoc Biol; 2000 May; 67(5):691-8. PubMed ID: 10811010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter.
    Gomolin HI; Yamaguchi Y; Paulpillai AV; Dvorak LA; Ackerman SJ; Tenen DG
    Blood; 1993 Sep; 82(6):1868-74. PubMed ID: 8400237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein): a GC box (-44 to -50) controls butyric acid induction of gene expression.
    Dyer KD; Rosenberg HF
    Life Sci; 2001 Jun; 69(2):201-12. PubMed ID: 11441910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
    Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
    Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily.
    Ackerman SJ; Corrette SE; Rosenberg HF; Bennett JC; Mastrianni DM; Nicholson-Weller A; Weller PF; Chin DT; Tenen DG
    J Immunol; 1993 Jan; 150(2):456-68. PubMed ID: 8419478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of Charcot-Leyden crystals by human basophils.
    Ackerman SJ; Weil GJ; Gleich GJ
    J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars.
    Dyer KD; Rosenberg HF
    Life Sci; 1996; 58(23):2073-82. PubMed ID: 8649192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils.
    Calafat J; Janssen H; Knol EF; Weller PF; Egesten A
    Eur J Haematol; 1997 Jan; 58(1):56-66. PubMed ID: 9020375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
    Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
    Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes.
    Dyer KD; Handen JS; Rosenberg HF
    Genomics; 1997 Mar; 40(2):217-21. PubMed ID: 9119387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
    Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
    Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
    Dvorak AM; MacGlashan DW; Warner JA; Letourneau L; Morgan ES; Lichtenstein LM; Ackerman SJ
    Clin Exp Allergy; 1997 Apr; 27(4):452-74. PubMed ID: 9146940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence.
    Handen JS; Rosenberg HF
    J Biol Chem; 1997 Jan; 272(3):1665-9. PubMed ID: 8999843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells.
    Zhou Z; Tenen DG; Dvorak AM; Ackerman SJ
    J Leukoc Biol; 1992 Dec; 52(6):588-95. PubMed ID: 1464731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
    Dvorak AM; Ackerman SJ
    Lab Invest; 1989 Apr; 60(4):557-67. PubMed ID: 2709814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human homolog of eosinophil major basic protein.
    Plager DA; Adolphson CR; Gleich GJ
    Immunol Rev; 2001 Feb; 179():192-202. PubMed ID: 11292023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
    McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
    EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein.
    Than NG; Sumegi B; Than GN; Berente Z; Bohn H
    Placenta; 1999 Nov; 20(8):703-10. PubMed ID: 10527825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils.
    Golightly LM; Thomas LL; Dvorak AM; Ackerman SJ
    J Leukoc Biol; 1992 Apr; 51(4):386-92. PubMed ID: 1373430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.